New Study: Medical Cannabis Linked to 40% Opioid Reduction in UK Pain Patients

Researchers at King College London analysed outcomes for 850 patients prescribed cannabis for chronic pain across five UK clinics between 2021 and 2023. The study found that 40% achieved a clinically significant reduction in opioid use (defined as 25% or greater), with 12% discontinuing opioids entirely. The research adds to an emerging body of evidence supporting opioid-sparing approaches to pain management.